Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pawlitzki

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
NPJ Digital Medicine|March 4, 2025
Evaluating base and retrieval augmented LLMs with document or online support for evidence based neurologyLars Masanneck, Sven G Meuth, Marc Pawlitzki
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2026
Finite depletion, sustained control: can impulse therapy prevent rebound activity in multiple sclerosis?Marc Pawlitzki, Lars Masanneck, Antonio Scalfari, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 11, 2021
Alemtuzumab-induced Alopecia areata - a case report and systematic literature review of adverse events associated with AlemtuzumabElsa Dikeoulia, Matthias Neufeld, Marc Pawlitzki, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2021
Elsa Dikeoulia, Matthias Neufeld, Marc Pawlitzki, et al.
Current Opinion in Neurology|May 6, 2025
Immunology of multiple sclerosis: an updatePatricia Kirschner, Marc Pawlitzki, Hans-Peter Hartung, et al.
International Journal of Molecular Sciences|June 2, 2021
Fc-Receptor Targeted Therapies for the Treatment of <i>Myasthenia gravis</i>Christian W Keller, Marc Pawlitzki, Heinz Wiendl, et al.
Journal of Medical Internet Research|October 29, 2025
Evaluating Web Retrieval-Assisted Large Language Models With and Without Whitelisting for Evidence-Based Neurology: Comparative StudyLars Masanneck, Paula Zoe Epping, Sven G Meuth, et al.
European Journal of Neurology|March 7, 2022
Sirolimus leads to rapid and sustained clinical improvement of motor deficits in a patient with inclusion body myositisMarc Pawlitzki, Christopher Nelke, Melanie Korsen, et al.
Neurology. Clinical Practice|May 8, 2024
The PNS Nurse Program: A Health Care Support Concept for Patients With Immune-Mediated Peripheral Nervous System DiseasesMarc Pawlitzki, Marcia Gasis, Lars Masanneck, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 4, 2023
Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?Volkmar Leßmann, Georgia-Ioanna Kartalou, Thomas Endres, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
NPJ Digital Medicine|March 4, 2025
Evaluating base and retrieval augmented LLMs with document or online support for evidence based neurologyLars Masanneck, Sven G Meuth, Marc Pawlitzki
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2026
Finite depletion, sustained control: can impulse therapy prevent rebound activity in multiple sclerosis?Marc Pawlitzki, Lars Masanneck, Antonio Scalfari, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 11, 2021
Alemtuzumab-induced Alopecia areata - a case report and systematic literature review of adverse events associated with AlemtuzumabElsa Dikeoulia, Matthias Neufeld, Marc Pawlitzki, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2021
Elsa Dikeoulia, Matthias Neufeld, Marc Pawlitzki, et al.
Current Opinion in Neurology|May 6, 2025
Immunology of multiple sclerosis: an updatePatricia Kirschner, Marc Pawlitzki, Hans-Peter Hartung, et al.
International Journal of Molecular Sciences|June 2, 2021
Fc-Receptor Targeted Therapies for the Treatment of <i>Myasthenia gravis</i>Christian W Keller, Marc Pawlitzki, Heinz Wiendl, et al.
Journal of Medical Internet Research|October 29, 2025
Evaluating Web Retrieval-Assisted Large Language Models With and Without Whitelisting for Evidence-Based Neurology: Comparative StudyLars Masanneck, Paula Zoe Epping, Sven G Meuth, et al.
European Journal of Neurology|March 7, 2022
Sirolimus leads to rapid and sustained clinical improvement of motor deficits in a patient with inclusion body myositisMarc Pawlitzki, Christopher Nelke, Melanie Korsen, et al.
Neurology. Clinical Practice|May 8, 2024
The PNS Nurse Program: A Health Care Support Concept for Patients With Immune-Mediated Peripheral Nervous System DiseasesMarc Pawlitzki, Marcia Gasis, Lars Masanneck, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 4, 2023
Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?Volkmar Leßmann, Georgia-Ioanna Kartalou, Thomas Endres, et al.
Pageof 14